Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

ERGIC and Golgi 2 (ERGIC2) Peptide

ERGIC2 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN976426
  • Target See all ERGIC2 products
    ERGIC2 (ERGIC and Golgi 2 (ERGIC2))
    Origin
    Human
    Source
    • 3
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Characteristics
    This is a synthetic peptide designed for use in combination with anti-ERGIon Channel2 antibody (Catalog #: ARP39265_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Purification
    Purified
  • Application Notes
    Each Investigator should determine their own optimal working dilution for specific applications.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Concentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Handling Advice
    Avoid repeated freeze-thaw cycles.
    Storage
    -20 °C
    Storage Comment
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    ERGIC2 (ERGIC and Golgi 2 (ERGIC2))
    Synonyms
    ptx1 Peptide, MGC75899 Peptide, zgc:64005 Peptide, Erv41 Peptide, PTX1 Peptide, cd002 Peptide, 1200009B18Rik Peptide, 4930572C01Rik Peptide, AA408438 Peptide, Ptx1 Peptide, RGD1310606 Peptide, ERGIC and golgi 2 Peptide, ERGIC and golgi 2 S homeolog Peptide, ergic2 Peptide, ERGIC2 Peptide, ergic2.S Peptide, Ergic2 Peptide
    Background
    ERGIon Channel2 possibly play role in transport between endoplasmic reticulum and Golgi. ERGIon Channel2 is downregulated in prostate cancer. ERGIon Channel2 may play an important role in the growth and tumorigenicity of PC-3 prostate tumor cells. Ectopic expression of a partial sequence of ERGIon Channel2 as a VP22-fusion protein in prostate cancer cell line, PC-3, induced cellular senescence. Interferon-beta (IFN-beta) and a number of IFN-inducible genes were upregulated by the ERGIon Channel2-VP22 fusion protein.

    Alias Symbols: PTX1, CDA14, Erv41, cd002

    Protein Size: 377
    Molecular Weight
    43 kDa
    Gene ID
    51290
    NCBI Accession
    NM_016570, NP_057654
    UniProt
    Q96RQ1
You are here:
Support